Top-News
Biotechnologie USA

Ocular Therapeutix Inc Aktie

Aktie
WKN:  A1180P ISIN:  US67576A1007 US-Symbol:  OCUL
8,80 $
+0,28 $
+3,29%
7,7822 € 20:44:13 Uhr
Depot/Watchlist
Aktienanzahl *
157,22 Mio.
Marktkapitalisierung *
1,15 Mrd. €
Streubesitz
13,16%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 05.03.2025

Ocular Therapeutix Inc News

19.02.24 - PR Newswire
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain ...
12.02.24 - PR Newswire
Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks?
Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences, or Sunworks? PR Newswire
27.09.22 - PR Newswire
Thinking about buying stock in Equillium, Marathon Digital, Missfresh, Ocular Therapeutix, or Riot Blockchain?
Thinking about buying stock in Equillium, Marathon Digital, Missfresh, Ocular Therapeutix, or Riot Blockchain? PR Newswire
12.04.22 - PR Newswire
AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery PR Newswire
29.11.21 - Aktienwelt360
3 Small-Cap-Aktien, die jetzt für langfristige Anleger ein Kauf sind
Wichtige Punkte Renalytix vermarktet einen Diagnoseservice, der dem US-​Service Medicare jedes Jahr Milliarden einsparen könnte. Ocular Therapeutix stellt eine ...
23.07.21 - PR Newswire
Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences?
Thinking about buying stock in Acorda Therapeutics, Ocular Therapeutix, Ocugen, Aerpio Pharmaceuticals, or Anavex Life Sciences? PR Newswire
16.02.21 - PR Newswire
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences?
Thinking about buying stock in Salarius Pharmaceuticals, KemPharm, Ocular Therapeutix, Boxlight Corp, or Endra Life Sciences? PR Newswire
17.06.20 - PR Newswire
Thinking about buying stock in Celsion Corp, Alkaline Water Company, Salem Media Group, Ocular Therapeutix, or Delta Air Lines?
Thinking about buying stock in Celsion Corp, Alkaline Water Company, Salem Media Group, Ocular Therapeutix, or Delta Air Lines? PR Newswire
15.05.20 - PR Newswire
Thinking about buying stock in VBI Vaccines, Aphria, Ocular Therapeutix, New Age Beverages, or General Electric?
Thinking about buying stock in VBI Vaccines, Aphria, Ocular Therapeutix, New Age Beverages, or General Electric? PR Newswire
28.04.20 - PR Newswire
Thinking about buying stock in Aytu Bioscience, SmileDirectClub, Ocular Therapeutix, Six Flags Entertainment, or MGM Resorts?
Thinking about buying stock in Aytu Bioscience, SmileDirectClub, Ocular Therapeutix, Six Flags Entertainment, or MGM Resorts? PR Newswire
31.08.17 - PR Newswire
EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL
EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL PR Newswire
25.08.17 - PR Newswire
Bernstein Liebhard LLP Announces That Only 10 Days Remain To File A Motion For Lead Plaintiff In A Class Action Filed Against Ocular Therapeutix, Inc.
Bernstein Liebhard LLP Announces That Only 10 Days Remain To File A Motion For Lead Plaintiff In A Class Action Filed Against Ocular Therapeutix, Inc. PR Newswire
25.07.17 - PR Newswire
Block & Leviton Reminds Ocular Therapeutix, Inc. (OCUL) Shareholders Of Important Deadline In Securities Fraud Class Action And Encourages Them To Contact The Firm
Block & Leviton Reminds Ocular Therapeutix, Inc. (OCUL) Shareholders Of Important Deadline In Securities Fraud Class Action And Encourages Them To Contact The Firm PR ...
25.07.17 - PR Newswire
OCUL Investors Update: Hagens Berman Alerts Investors in Ocular Therapeutix, Inc. to Expanded Class Period in Pending Securities Class Action, Reminds Them of the September 5, 2017 Lead Plaintiff Dead
OCUL Investors Update: Hagens Berman Alerts Investors in Ocular Therapeutix, Inc. to Expanded Class Period in Pending Securities Class Action, Reminds Them of the ...
24.07.17 - PR Newswire
Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics
Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., ...
21.07.17 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline - OCUL
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline - ...
19.07.17 - PR Newswire
OCULAR THERAPEUTIX ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ocular Therapeutix, Inc. To Contact The Firm
OCULAR THERAPEUTIX ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ocular Therapeutix, Inc. To Contact The Firm PR Newswire
19.07.17 - PR Newswire
Investor Alert: Kaplan Fox Announces Investigation Of Ocular Therapeutix, Inc.
Investor Alert: Kaplan Fox Announces Investigation Of Ocular Therapeutix, Inc. PR Newswire
12.07.17 - PR Newswire
EQUITY ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Ocular Therapeutix, Inc.
EQUITY ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. PR Newswire
12.07.17 - PR Newswire
RM LAW Announces Class Action Lawsuit Against Ocular Therapeutix, Inc.
RM LAW Announces Class Action Lawsuit Against Ocular Therapeutix, Inc. PR Newswire

Newssuche

Videos

newspaper
30.04.25 +22,47%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »